The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
Clinical trial NCT02409290 · COMPLETED
Trial details
- NCT number
- NCT02409290
- Sponsor
- IUATLD, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2022-05-13
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.